Evidence map›Paper›PMID 39135397›Full record

Trial reportJournal of evidence-based integrative medicine

Aesthetic Radiofrequency Associated with

Greissi Tatieli Franke Tremêa, Karine Raquel Uhdich Kleibert, Lenara Schalanski Krause, Ana Paula Weber Fell, Anais Regina Scapini, Keli Wilchen Marschall, Cristiano Sartori Baiotto, Martha Héllen Tremêa da Silva, José Antonio Gonzalez da Silva, Christiane de Fátima Colet

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Journal of evidence-based integrative medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Greissi Tatieli Franke TremêaUniversidade Regional do Noroeste do Estado do Rio Grande do Sul - UNIJUÍ, Ijui, Brazil.
Karine Raquel Uhdich KleibertUniversidade Regional do Noroeste do Estado do Rio Grande do Sul - UNIJUÍ, Ijui, Brazil.
Lenara Schalanski KrauseUniversidade Regional do Noroeste do Estado do Rio Grande do Sul - UNIJUÍ, Ijui, Brazil.
Ana Paula Weber FellUniversidade Regional do Noroeste do Estado do Rio Grande do Sul - UNIJUÍ, Ijui, Brazil.
Anais Regina ScapiniUniversidade Regional do Noroeste do Estado do Rio Grande do Sul - UNIJUÍ, Ijui, Brazil.
Keli Wilchen MarschallUniversidade Regional do Noroeste do Estado do Rio Grande do Sul - UNIJUÍ, Ijui, Brazil.
Cristiano Sartori BaiottoUniversidade Regional do Noroeste do Estado do Rio Grande do Sul - UNIJUÍ, Ijui, Brazil.
Martha Héllen Tremêa da SilvaUniversidade Regional do Noroeste do Estado do Rio Grande do Sul - UNIJUÍ, Ijui, Brazil.
José Antonio Gonzalez da SilvaUniversidade Regional do Noroeste do Estado do Rio Grande do Sul - UNIJUÍ, Ijui, Brazil.
Christiane de Fátima ColetUniversidade Regional do Noroeste do Estado do Rio Grande do Sul - UNIJUÍ, Ijui, Brazil.ORCID 0000-0003-2023-5088

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective were to evaluate the effects of supplementation of standardized dry extract of Rosmarinus officinalis (RO) and the application of aesthetic radiofrequency on the oxidative stress markers catalase (CAT), superoxide dismutase (SOD), non-protein thiols (NP-SH), and thiobarbituric acid reactive species (TBARS) and the biochemical markers triglycerides, total cholesterol, high density lipoprotein (HDL) cholesterol, glutamic-oxaloacetic transaminase (TGO/AST), pyruvic-glutamic transaminase (TGP/ALT), gamma glutamyl transpeptidase (gamma-GT), and creatinine. This study included 32 women received the aesthetic therapy to reduce localized fat. They were divided into the control group (n = 8) receiving placebo capsules and the intervention group (n = 24) subdivided into Group A, B, and C, each with eight members receiving supplementation with 100, 500, and 1000 mg/day of standardized dry extract of RO, respectively. The Universal Trial Number (UTN) - U1111-1274-6255. Supplementation with RO (500 mg/day) demonstrated a reduction in oxidative stress (quantified with through a significant increase in NP-SH and a reduction in SOD and CAT enzymes). The radiofrequency aesthetic treatment did not promote an increase in oxidative stress; however, it caused significant changes in total cholesterol, HDL cholesterol, and creatinine. RO is a plant with antioxidant effects and its oral consumption is safe in selected women subjects in hepatic and renal markers.

Indexed as

Dietary SupplementsOxidative StressPlant ExtractsRosmarinusAdultAntioxidantsBiomarkersCatalaseDouble-Blind MethodFemaleHumansMiddle AgedRadio WavesSuperoxide DismutaseYoung AdultAntioxidantsBiomarkersCatalasePlant ExtractsSuperoxide Dismutasecatalaseoxidative stress markersRosemarysuperoxide dismutase

Identifiers

PMID39135397
PMCPMC11320689

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.